Beispiel: Heart Attack

Klinische Studien gesponsert von Pharmaxis

Insgesamt 34 ergebnisse

NCT04676529

Noch nicht rekrutiert

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

Bedingungen: Myelofibrosis
NCT04183517

Abgeschlossen

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

Bedingungen: Pharmacokinetics
NCT02134353

Abgeschlossen

A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

Bedingungen: Cystic Fibrosis
NCT01883531

Abgeschlossen

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Bedingungen: Cystic Fibrosis
NCT01380236

Zurückgezogen

A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

Bedingungen: Asthma
NCT01158898

Abgeschlossen

Efficacy of TPI ASM8 During a 14-Day Allergen Challenge

Bedingungen: Asthma
NCT01076491

Abgeschlossen

High Dose Inhaled Mannitol Study

Bedingungen: Bronchiectasis
NCT00914433

Zurückgezogen

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

Bedingungen: Chronic Obstructive Pulmonary Disease
NCT00822861

Abgeschlossen

Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

Bedingungen: Asthma
NCT00792714

Abgeschlossen

Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients

Bedingungen: Cystic Fibrosis
NCT00779077

Abgeschlossen

Cystic Fibrosis (CF) Flow Rates Study

Bedingungen: Cystic Fibrosis
NCT00730977

Abgeschlossen

A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device

Bedingungen: Healthy; Bronchiectasis
NCT00669331

Abgeschlossen

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

Bedingungen: Bronchiectasis
NCT00656565

Abgeschlossen

Inspiratory Flow and Volumes in Bronchiectatics

Bedingungen: Bronchiectasis
NCT00630812

Abgeschlossen

Long Term Administration of Inhaled Mannitol in Cystic Fibrosis

Bedingungen: Cystic Fibrosis
NCT00550797

Abgeschlossen

Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma

Bedingungen: Allergic Asthma
NCT00531414

Abgeschlossen

Inspiratory Flow Using the Osmohaler

Bedingungen: Asthma
NCT00483743

Abgeschlossen

Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients

Bedingungen: Copd Bronchitis
NCT00455130

Abgeschlossen

A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

Bedingungen: Cystic Fibrosis
NCT00446771

Abgeschlossen

A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects

Bedingungen: Healthy Volunteers
NCT00446680

Abgeschlossen

Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

Bedingungen: Cystic Fibrosis
NCT00446667

Zurückgezogen

A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD

Bedingungen: COPD; Exacerbation
NCT00402948

Beendet

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

Bedingungen: Asthma
NCT00327808

Abgeschlossen

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

Bedingungen: Asthma
NCT00277537

Abgeschlossen

Safety and Efficacy of Bronchitol in Bronchiectasis

Bedingungen: Bronchiectasis